Tempus AI Shares Rise on New Angiosarcoma Research Collaboration
Tempus AI announces research collaboration with Angiosarcoma Awareness, analyzing ~600 patient records with paired DNA/RNA data to accelerate rare cancer insights.
/ 220 items
#andre↓
OVHcloud Accelerates Growth in Q3 but Shares Tumble on CapEx Concerns
Public cloud revenue jumped 20% at OVHcloud in Q3, driving overall growth. However, shares dropped on concerns over higher capital spending and cautious full-year outlook.
BlackBerry Raises Full-Year Revenue Guidance After Strong Q1 Beat
The company beat estimates and raised its full-year revenue guidance to $594–621 million, driven by QNX and Secure Communications growth.
Rosenblatt Calls CoreWeave the “De Facto Operating System for AI” with Buy Rating and 148% Upside
Nearly 50 data centers, $100B backlog, and 77% expected annual growth through 2030.
ARS Pharmaceuticals Shares Plunge as Neffy Misses July Insurance Wins
Despite the setback, Florida Medicaid coverage begins July 1, the company cut 2026 expenses to $248M, and it remains on track for cash-flow breakeven in 2027.
Merck KGaA Bolsters Life Sciences Portfolio with $11.3B Bio-Techne Acquisition
Acquisition of a medical tools maker will be the German group’s biggest in over a decade.